SCHEMBL2337792

SCHEMBL2337792

CN(C)C(O)CCC(c1ccc(F)cc1)c1ccc(C#N)cc1CO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.38
CYP19A1 P11511 2/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP2J2 P51589 1/20 0.35
AOC3 Q16853 1/20 0.34
NSD2 O96028 1/20 0.33
MCHR1 Q99705 1/20 0.33
SCN9A Q15858 2/20 0.32
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
PTGDR Q13258 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CACNA1F O60840 2/20 0.31
HTR1A P08908 2/20 0.31
ADORA3 P0DMS8 2/20 0.31
DRD2 P14416 2/20 0.31
DRD1 P21728 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27836479 1.00 EPHX2 (0.38) EPHX2CYP19A1CYP2C9CYP2C19CYP2J2
SCHEMBL27836477 1.00 EPHX2 (0.38) EPHX2CYP19A1CYP2C9CYP2C19CYP2J2
SCHEMBL3986098 0.80 AOC3 (0.36) EPHX2CYP19A1CYP2C9CYP2C19CYP2J2
SCHEMBL27816963 0.80 AOC3 (0.36) EPHX2CYP19A1CYP2C9CYP2C19CYP2J2
SCHEMBL27702058 0.80 AOC3 (0.36) EPHX2CYP19A1CYP2C9CYP2C19CYP2J2
Bromide SCHEMBL4734510 0.79 AOC3 (0.36) EPHX2CYP19A1CYP2C9CYP2C19CYP2J2
SCHEMBL907710 0.78 EPHX2 (0.38) EPHX2CYP19A1AOC3SCN9APTGDR2
SCHEMBL8203438 0.71 SLC6A4 (0.41) HTR1ADRD1HTR2AHRH1OPRM1
SCHEMBL5971914 0.70 NSD2 (0.34) EPHX2CYP2C9CYP2C19CYP2J2AOC3
SCHEMBL5972626 0.70 NSD2 (0.34) EPHX2CYP2C9CYP2C19CYP2J2AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2360150-A1 Method for the separation of intermediates which may be used for the preparation of escitalopram H. Lundbeck A/S (DK) 2011-08-24 EP disclosed
EP-2061753-A1 METHOD FOR MANUFACTURE OF ESCITALOPRAM H.Lundbeck A/S (DK) 2009-05-27 EP disclosed
WO-2009033488-A1 METHOD FOR MANUFACTURE OF ESCITALOPRAM H. LUNDBECK A/S (DK) 2009-03-19 WO disclosed
WO-2008059514-A2 PROCESS FOR PREPARING ESCITALOPRAM CADILA HEALTHCARE LIMITED (IN) 2008-05-22 WO disclosed